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Abstract:
Ideally, the data used for robust spatial prediction of disease distribution 
should be both high-resolution and spatially expansive. However, such 
in-depth and geographically broad data are rarely available in practice. 
Instead, researchers usually acquire either detailed epidemiological data 
with high resolution at a small number of active sampling sites, or more 
broad-ranging but less precise data from passive case surveillance. 
We propose a novel inferential framework, capable of simultaneously 
drawing insights from both passive and active data types. We developed 
a Bayesian latent point process approach, combining active data 
collection in a limited set of points, where in-depth covariates are 
measured, with passive case detection, where error-prone, large-scale 
disease data are accompanied only by coarse or remotely-sensed 
covariate layers. 
Using the example of malaria, we tested our method’s efficiency under 
several hypothetical scenarios of reported incidence in different 
combinations of imperfect detection and spatial complexity of the 
environmental variables. 
We provide a simple solution to a widespread problem in spatial 
epidemiology, combining latent process modelling and spatially 
autoregressive modelling. By using active sampling and passive case 
detection in a complementary way, we achieved the best-of-both-worlds, 
in effect, a formal calibration of spatially extensive, error-prone data by 
localised, high-quality data. 
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7 Abstract 
8 Ideally, the data used for robust spatial prediction of disease distribution should be both high-
9 resolution and spatially expansive. However, such in-depth and geographically broad data are rarely 
10 available in practice. Instead, researchers usually acquire either detailed epidemiological data with 
11 high resolution at a small number of active sampling sites, or more broad-ranging but less precise 
12 data from passive case surveillance. 
13 We propose a novel inferential framework, capable of simultaneously drawing insights from both 
14 passive and active data types. We developed a Bayesian latent point process approach, combining 
15 active data collection in a limited set of points, where in-depth covariates are measured, with 
16 passive case detection, where error-prone, large-scale diseas  data are accompanied only by coarse 
17 or remotely-sensed covariate layers.
18 Using the example of malaria, we tested our method’s efficiency under several hypothetical 
19 scenarios of reported incidence in different combinations of imperfect detection and spatial 
20 complexity of the environmental variables.
21 We provide a simple solution to a widespread problem in spatial epidemiology, combining latent 
22 process modelling and spatially autoregressive modelling. By using active sampling and passive case 
23 detection in a complementary way, we achieved the best-of-both-worlds, in effect, a formal 
24 calibration of spatially extensive, error-prone data by localised, high-quality data. 
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25 Keywords: Bayesian modelling, disease mapping, imperfect detection, latent point process, N-
26 mixture models, spatial epidemiology.
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28 INTRODUCTION
29 Predictive maps of disease risk, typically obtained by modelling the spatial heterogeneity in disease 
30 incidence as a function of underlying covariates, can be crucial for targeting effective control and 
31 surveillance 1-6. However, reliable prediction at the landscape scale is often hindered by lack of 
32 appropriate, high resolution spatial data. Traditionally, incidence data and potential explanatory 
33 covariates are collected either systematically – using active sampling by researchers – or 
34 opportunistically – from clinical records reported at health facilities. Each of these sampling 
35 strategies has its own limitations 7. For example, by collecting detailed data for both disease 
36 incidence and related covariates, data from active sampling allows models to achieve high 
37 explanatory power but not to make large-scale extrapolation and predictions in areas where fine 
38 scale covariates are not directly measurable 8, 9. On the other hand, passive sampling yields data 
39 from a large number of geographically dispersed cases which are more amenable for large scale 
40 predictions, but these data often suffer from severe reporting biases 10-13 and can be paired with 
41 only coarse environmental covariates that have limited explanatory power 4. As the drawbacks of 
42 one strategy are clearly the strengths of the other, modelling frameworks that consider these two 
43 types of data simultaneously and complementarily would strengthen our biological insights and 
44 predictive power.
45 Active sampling is typically conducted by research teams that focus on a small number of 
46 predetermined locations, with collection of detailed environmental or epidemiological variables 
47 including clinical samples 9, 14-19, entomological indicators (for vector-borne disease) 17, 18, 20-22,  human 
48 demographic and socio-economic factors 9, 19, 23, 24 or fine-scale environmental conditions 25, 26. Such 
49 data can provide high power for explaining variation in risk across focal sites 7, but lack predictive 
50 breadth across space because many of the  crucial covariates are not available for un-sampled 
51 locations 9. 
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52 Clinical records from passive case detection offer the potential of expansive descriptions of spatial 
53 incidence patterns. However, since these incidence data often arise from self-reporting at health 
54 centres, they can be biased by their opportunistic nature. Reporting bias is well acknowledged for 
55 numerous infectious disease systems 27-29 and can be expressed as a combined function of distance 
56 from health facilities, the likelihood of asymptomatic cases and sociodemographic factors 10-13, 30-35 or 
57 more complex measures of travel time 36. Despite this limitation, health centre surveys remain the 
58 primary source of information for disease monitoring. Another drawback of spatial models of 
59 incidence data gathered from passive case detection, relates to the availability of environmental 
60 predictor data. If the locality of the patient is recorded, incidence data can be spatially plotted but 
61 researchers and public health workers are unlikely to be able to directly measure some detailed 
62 explanatory variables at those localities. Therefore, when modelling the incidence data, only large-
63 scale but coarse layers are customarily considered. While these bring more geographically expansive 
64 information than the highly localised survey data, they generally consist of remotely sensed 
65 covariates and summary records such as bioclimatic, geomorphological, vegetation indexes, human 
66 population density or road networks 9, 37-40, that typically contribute limited explanatory power.
67 Some studies 7, 14-16, 23, 41-44 make use of data from both active and passive case detections together, 
68 but focus on independent analysis and comparison of results from these separate data sources 
69 rather than integrating them.  Analysing these two data sources jointly can be viewed as challenging 
70 15 because their limitations imply a trade-off between explanatory depth and predictive breadth. 
71 However, there is clearly an opportunity to achieve complementarity by analysing them on an 
72 integrated inferential framework. Here, for the first time, we develop a spatial statistical model 
73 combining these two sources of incidence data to harness the maximum amount of information for 
74 explanatory and predictive objectives.  
75 Our framework takes a novel approach to both the response and the explanatory variables. The dual 
76 nature of the incidence data requires specification of a statistical model that considers two different 
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77 aspects of likelihood, one for the localised but precise survey data, and another for the spatially 
78 extensive but imperfect clinical reporting data. We build this part of the approach on two 
79 cornerstones of the statistical literature: the point process model 45, 46 and the methodology of point 
80 transects 47. Point processes model events (e.g. infection cases) that occur continuously in space 
81 according to an unknown intensity (a spatial surface to be estimated as a function of covariates). We 
82 observe these events as arising from two different point transects, each having its own spatially 
83 heterogeneous observation model. The first type of observation point is the active sampling 
84 location, where cases are detected near-perfectly, but only for that particular set of geographical 
85 coordinates. The second type of observation point is a clinic, where cases of the disease are reported 
86 from a broad geographical region but with probabilities of detection that decay with distance from 
87 the clinic. Regarding the explanatory variables, some environmental variables are easily collectable 
88 for both passive case detection and active sampling points, but more important and powerful 
89 variables may be available only at the latter. By importing ideas from latent process modelling 48, 49 
90 we use the spatially extensive clinical data together with the data-rich survey data to reconstruct 
91 latent covariates that may be hidden from direct or remote observation. 
92 To validate the ability of our model to retrieve correct parameter values we require these scenarios 
93 to be accompanied by known intensity surfaces for both incidence and latent explanatory variables. 
94 These requirements cannot be satisfied by real data sets, so here we have acquired our scenarios via 
95 realistic simulation, motivating our examples from a real system of a vector-borne disease. To 
96 illustrate the generality of our approach, we have hypothesized multiple contrasting scenarios of 
97 reporting bias and spatial distribution of the latent process underlying disease incidence.
98 We chose malaria in West Africa as an ideal example of an important environmentally-dependent 
99 infectious  disease 50, 51, for which human  exposure and infection risk is highly spatially 
100 heterogeneous and dependent on crucial environmental variables that influence interactions 
101 between people, mosquitoes and parasites 40, 52. Control measures such as long-lasting insecticide 
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102 treated nets (LLINs) have been crucial for impeding contact between mosquitoes and people, and 
103 have led to substantial declines in malaria prevalence across Africa in the last decade 50, 51. However, 
104 the success of such an approach may be undermined by development of insecticide resistance in 
105 mosquitoes, particularly in West Africa where rates are among the highest in the world 53-55.  Copious 
106 and widespread data on reported cases are often available from clinics (see for example 
107 www.malariasurveys.org or www.dhsprogram.com), but detailed information on mosquito vector 
108 ecology and insecticide resistance is only available for a limited number of sites (e.g. 54, 56-58). These  
109 challenges exist for many other vector-borne diseases whose transmission is dependent on an 
110 ecological reservoir and rely on insecticide use for control, such as for example dengue, Zika and 
111 chikunguya viruses 59, Lyme and other tick-borne disease 60, schistosomiasis 61, Rift Valley Fever 62, 
112 human African trypanosomias 63 or West Nile Virus 64. 
113 METHODS
114 Modelling approaches
115 For a given area of interest subdivided into a regular grid, we consider as our sampling unit the grid 
116 cell . We first assume an underlying stochastic process  that generates numbers of cases 𝑖 ∈ {1,…,𝐾} 𝑓
117  according to an underlying, spatially heterogeneous rate . We also assume an observation 𝑁𝑖 𝜆𝑖
118 process  that allows a subset of the  cases to be reported at different sampling stations. We 𝑔 𝑁𝑖
119 distinguish between two types of sampling stations:  is the number of active sampling points (about 𝑆
120 which we are assuming a perfect and exclusive detection but at a small distance, i.e. within the cell 
121 that contains them). We denote by  the number of clinics (about which we are assuming an 𝐽
122 imperfect but long-ranging detection). The observation process  is therefore generating the vector 𝑔
123 of incidence data reported in each  cell at different stations 𝑖𝑡ℎ 𝑰𝑖 =
124 , given the vector of probabilities {𝐼1,𝑖,…, 𝐼𝑆,𝑖,  𝐼(𝑆 + 1),𝑖, …,  𝐼(𝑆 + 𝐽),𝑖, 𝑈𝑖} 𝑷𝑖 =
125 . represents the number of completely unreported cases in {𝑃1,𝑖,…, 𝑃𝑆,𝑖,  𝑃(𝑆 + 1),𝑖, …,  𝑃(𝑆 + 𝐽),𝑖, 𝑄𝑖} 𝑈𝑖 
126 each  cell (which is a missing value in the data), given the probability  of not reporting.𝑖𝑡ℎ 𝑄𝑖
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127 The general likelihood function of our models can be expressed as follows:
𝐿 = 𝐾∏
𝑖 = 1𝑓(𝑁𝑖|𝜆𝑖) 𝑔(𝑰𝑖|𝑷𝑖,𝑁𝑖)  [1]
128 We built our approach incrementally, developing three distinct modelling approaches with an 
129 increasing level of complexity to allow comparison between the routes that might have traditionally 
130 been followed to analyse data arising from active sampling (model 1) and passive case detection 
131 (model 2) with our new proposed route (model 3), which reconstructs the latent processes and 
132 estimates the emergent patterns of disease incidence with increased precision and accuracy. 
133 Model 1 – active sampling data only
134 Here, we consider data that would be collected from active sampling at just a limited number  of 𝑆
135 active survey sites.  To analyse the relationship between disease incidence and detailed measures of 
136 covariates at a set of predetermined survey points, model 1 takes the form of a Poisson Generalised 
137 Linear Model without any spatially explicit component. 
138 Although this is a straightforward model to fit using likelihood-based libraries in all statistical 
139 platforms, we fitted it using Bayesian methods 65 for consistency in the comparison with models 2 
140 and 3 that follow. The response variable is the number of observed diseases cases  at the location 𝑁𝑖
141 of the  survey. We assume here (for simplicity, but with no loss of generality) that all the cases at 𝑖𝑡ℎ
142 the survey location are recorded (hence, a local detection probability of 1 for each case), although 
143 we acknowledge that with conventional diagnostic tests some percentage of cases can be missed 66. 
144 If data are available on diagnostic sensitivity and specificity, our method can be readily extended by 
145 incorporating false negatives or positives. 
146 The model takes the form
Ni ~ Poisson (λi) [2]
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147 where the rate (λi) of disease incidence is 
ln (𝜆𝑖) = 𝛽0 +  𝑛∑
𝑘 = 1𝛽𝑘𝑋𝑖𝑘
[3]
148 The linear predictor on the right-hand-side of this expression comprises a set of  coefficients  and 𝑛 𝛽
149  explanatory variables  measured at the  survey location. 𝑛 𝑋 𝑖𝑡ℎ
150 Equations [2] and [3] can be generalised to take better account of specific features of the data. For 
151 example, it may be relevant to use overdispersed forms of the likelihood (relaxing the Poisson 
152 assumption) or more complicated functional forms of the linear predictor, involving polynomials, 
153 interactions or splines. 
154 Model 2 – passive case detection only
155 Here, we considered only data coming from passive case detection. This model maintained the basic 
156 structure of model 1, i.e. it is a Bayesian Poisson regression, with reported disease cases at human 
157 dwellings or communities surrounding the health centres as the response variable and the set of 
158 environmental variables as predictors.  Under our scenarios, we assumed that one of the key 
159 predictor variables (insecticide resistance , see model validation) could only be measured 𝐼𝑅
160 experimentally in active sampling sites, therefore we couldn’t include it in eq. [3]. 
161 We  introduced the estimation of bias in reporting disease cases given by the distance from the 
162 health centres, borrowing concepts from distance sampling theory 47, a group of methods, widely 
163 used to estimate the absolute abundance or spatial density of animal or plant populations. The key 
164 underlying concept is the estimation of a detection function ( ), which represents the decay in 𝑃(𝑑)
165 the probability of detecting an object with increasing distance (d) from the observer. Given the 
166 detection function and encounter rate, the absolute density of a population can be modelled at a 
167 given point, assuming perfect detection at the location of the observer . In our application, 𝑃(0) = 1
168 this has the interpretation that if a case arises in the immediate vicinity of the clinic ( ), then it is 𝑑≅0
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169 certain to be reported. A plausible, but flexible decay function is fitted to paired data of detections 
170 and distances. For example, detection of a malaria case from the  location at the  clinic, and can 𝑖𝑡ℎ 𝑗𝑡ℎ
171 be modelled as a half-normal function of distance from the health centre , by the following 47:  𝑑𝑖,𝑗
𝑝(𝑑𝑖,𝑗) = exp( ― 𝑑2𝑖,𝑗2𝜎2) [4]
172 where  is the shape parameter of the half-normal function (regulating how quickly the detection 𝜎
173 probability drops with distance). The distance  can be Euclidean, or a more complicated function of 𝑑
174 accessibility (e.g. affected by proximity between points along a given road network). 
175 Any given case may be reported to any one of the available clinics, but clinics nearby are more likely 
176 to receive the report. The probability of any one case being reported to any one clinic (accounting 
177 for other clinics) can be modelled in terms of the distances of all the clinics from the point of 
178 occurrence of the case, as follows
𝑃𝑖,𝑗 = 𝑝(𝑑𝑖,𝑗)
∑𝐽
𝑗 = 1𝑝(𝑑𝑖,𝑗) + 𝑄𝑖 [5]
179 The denominator here represents all possible outcomes, i.e. the probabilities that the case is 
180 reported to any one of J centres, and the probability that the case goes completely unreported:𝑃𝑄𝑖
𝑄𝑖 = 𝐽∏
𝑗 = 1[1 ― 𝑝(𝑑𝑖,𝑗)] [6]
181 Note that  is the standardised form of . In fact, is the probability of a case being 𝑃𝑖,𝑗 𝑝(𝑑𝑖,𝑗) 𝑝(𝑑𝑖,𝑗)
182 reported at a given clinic (considered in isolation), purely as a function of distance, whereas  is 𝑃𝑖,𝑗
183 the probability of reporting at a clinic, accounting for the effects of other clinics that are 
184 “competing” for the same reports and including , that is the probability of a case not being 𝑄𝑖
185 reported at all.
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186 The likelihood of a data set comprising clinic reports may then be written as a multinomial process. 
187 In particular, for a given number of actual cases   (see eq. [2]), the likelihood of reported disease 𝑁𝑖
188 cases  in the  cell for the clinics in the dataset is determined by the detection probabilities   𝑰𝑖 𝑖𝑡ℎ 𝐽 𝑷𝑖
189 that are function of distances between the  location and the clinics,  by𝑖𝑡ℎ
𝑰𝑖~𝑀𝑢𝑙𝑡𝑖𝑛𝑜𝑚𝑖𝑎𝑙(𝑁𝑖, 𝑷𝑖) [7]
190 where .𝑷𝑖 = {𝑃1,𝑖,…, 𝑃𝐽,𝑖, 𝑄𝑖}
191 Fitting model 2 to the data yelded estimates of the shape parameter of the detection function (eq. 
192 [4]) and parameters of eq. [3]. Although it had no spatially explicit component, we used model 2 to 
193 generate a reconstruction of the patterns of incidence across space, based on the coarse-level 
194 environmental covariates. Hence this model did not benefit from the fine-resolution covariates that 
195 could only be measured by detailed experimental methods at survey points. 
196 Model 3 – active and passive data combined
197 The process and observation model for this joint approach to data took the form of eqs. [2] and [7] 
198 respectively. However, just like in model 1, eq. [3] used the full set of predictors, including the 
199 partly-latent variable (i.e. insecticide resistance, available only for active sampling points but not for 
200 regions of passive case detection data collection and the rest of space). Our model for the latent 
201 variable  postulated a spatial autocorrelation structure 67, implying that even though we may not 𝐼𝑅
202 know the values of the latent variable at two points in space, we can express a relationship about 
203 their expected degree of similarity. Any pair of  cells in our grid, say  and , 𝐾 𝑖 ∈ {1,…,𝐾} 𝑘 ∈ {1,…,𝐾}
204 were assumed to have a covariance, specified as a decreasing function of their distance
𝑐𝑜𝑣𝑖,𝑘 =  exp ( ― 𝜌 𝑑𝑖,𝑘) [8]
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205 With . Again, this is one of many possible structures and our overall approach is not 𝜌 ≥ 0
206 constrained to this functional form. 
207 The distribution of the latent variable  in all the  cells, was therefore modelled 𝑰𝑹 = {𝐼𝑅1, …, 𝐼𝑅𝐾} 𝐾
208 as a Gaussian field from an m-dimensional multivariate normal distribution, where each of the 
209 dimensions represented the probability density of a cell in space.
  ∑)𝐼𝑅𝑖 ~ 𝑀𝑉𝑁(𝜇, [9]
210 Here, the mean vector  has length  (the total number of cells in geographical space), and ∑  is a 𝜇 𝐾
211  spatial covariance matrix 68 with values of 1 on the diagonal and values  for the  row 𝐾 × 𝐾 𝑐𝑜𝑣𝑖,𝑘 𝑖
212 and   column from eq. [8]. 𝑘
213 Model 3, hence, is fitted exactly as model 2 according to eq. [7], but the linear predictor function 
214 (eq. [3]), included all the covariates, unlike model 2, which was missing the covariate of IR.  In 
215 particular, IR observations were used where available (at active sampling points), assuming that they 
216 were realisations from eq. [9].
217 Model validation
218 We used simulated data on malaria incidence and insecticide resistance within the primary mosquito 
219 vectors to validate our models. Our specific validation aims were to 1) evaluate the match between 
220 the posterior distribution of the coefficients and the simulation process that generated the data; 2) 
221 estimate bias in reporting the clinical data as a function of distance between the location of a clinic 
222 and the village where the patient resides; 3) recreate the missing covariate of insecticide resistance 
223  and to reconstruct the true incidence .𝐼𝑅 𝑁
224 Our simulation borrowed its setting from a study currently ongoing in Southwest Burkina Faso (MiRA 
225 – Malaria in Insecticide Resistant Africa, Wellcome Trust 200222/Z/15/Z). The study covers an area 
226 of approx. 6000 km2 in the health district of Banfora in south-western Burkina Faso, comprising 
227 primarily West Sudanian savannah which experiences a rainy season from May to October with little 
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228 rain in other months.  Malaria transmission is stable throughout the year but peaks from May to 
229 November. The major vectors are Anopheles gambiae and An. funestus.  Like many other areas of 
230 Africa, the primary malaria control strategy is long lasting insecticidal nets (LLINs) that are 
231 distributed at high coverage across the country (Burkina Faso National Malaria Control Program, 
232 unpublished data). In contrast to some areas of Africa, recent LLIN distribution campaigns have had 
233 little impact on malaria prevalence and it is hypothesized that this may be due to high levels of 
234 insecticide resistance in local vector populations 69, which are amongst the highest on record. 
235 Resistance to pyrethroid insecticides is widespread. Mortality after exposure (defined by the World 
236 Health Organization (WHO) as the response to the stipulated discriminating dose of permethrin) 
237 ranges from 5-20% 20. For the purposes of data simulation we assume that active sampling of malaria 
238 infections and insecticide resistance levels is carried out in 12 villages, and that passive case data is 
239 available from patients reporting to from 8 health centres distributed throughout the study area.  
240 This number and distribution of passive and active sampling site was selected to represent the 
241 distribution of health facilities and likely maximum amount of active survey data available. 
242 For the simulation, we considered a square grid with a 1km2 resolution covering the study area. We 
243 generated a dataset with reported incidence in each cell of the grid under a binomial N-mixture 
244 model 70, 71 by combining two different processes: a state model, i.e. the biological process that 
245 generates malaria infection cases, and an observation model, i.e. the process that affects the 
246 probability that infection cases are reported to a health centre.
247 To simulate the biological process, we considered the average altitude in the cell, average yearly 
248 temperature (TEMP), annual rainfall (RAIN), human density (HUM), normalised difference vegetation 
249 index (NDVI) and insecticide resistance (IR) in mosquitoes as potential predictors 9, 38, 72-77. 
250 Temperature and rainfall were derived from the WorldClim database (www.worldclim.org). NDVI 
251 values were obtained using the package MODIStsp for R 78. To create the layer of human density, we 
252 used a kernel density estimation 79 using GPS points of the villages (307) in the study area and the 
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253 population census in each village (1755 ± 1804 mean ± dev. std., Institut national de la statistique et 
254 de la démographie, unpublished data ) as weight field. Kernel bandwidth was chosen so as to 
255 minimize the least-squares cross validation score (hlscv) 80. 
256 Insecticide resistance reporting has improved over time, and global maps of insecticide resistance at 
257 coarse resolutions are now becoming available 77. However, little is known about its spatial 
258 distribution at local scale 81. Therefore, to explore out model’s ability to retrieve latent variables of 
259 differing spatial complexity, insecticide resistance was simulated by hypothesizing 3 different 
260 scenarios of increasing spatial autocorrelation, with parameter  of eq. [8] set respectively to 𝜌 𝜌1
261 ,  and  (Fig. 1, IR1, IR2, IR3). = 3.0 𝜌2 = 0.7 𝜌3 = 0.3
262 The number of malaria cases, or true incidence, in each cell (Ni) was assumed to have a positive 
263 relationship with temperature 9, 74, rainfall 9, 73, 74, human density 9, NDVI 9, 37, 38, 72 and insecticide 
264 resistance 76, and was simulated from eq. [2] using the linear predictor
265 log (𝜆𝑖) = 𝛽0 + 𝛽𝐻𝑈𝑀𝐻𝑈𝑀𝑖 + 𝛽𝑁𝐷𝑉𝐼𝑁𝐷𝑉𝐼𝑖 + 𝛽𝑅𝐴𝐼𝑁 𝑅𝐴𝐼𝑁𝑖 + 𝛽𝑇𝐸𝑀𝑃𝑇𝐸𝑀𝑃𝑖 +  𝛽𝐼𝑅𝐼𝑅𝑖
266 We set the equation’s coefficients to the values 0 = 2.90, HUM = 0.50, NDVI = 0.30, RAIN = 0.20, 𝛽 𝛽 𝛽 𝛽
267 TEMP = 0.25, IR = 0.50. Having 3 distinct scenarios of insecticide resistance ,  and  we 𝛽 𝛽 𝐼𝑅1 𝐼𝑅2 𝐼𝑅3
268 obtained 3 scenarios of malaria infection cases ,  and   𝑁1𝑖 𝑁2𝑖 𝑁3𝑖.
269 For the observation process, we accounted for simulated bias in reporting cases in each cell of the 
270 grid, by considering a probability of reporting as a function of the distance between a given cell and 
271 each health centre. We set the detection probabilities in each cell  in accordance with eq. [4] 𝑃(𝑖,𝑗)
272 with  being the Euclidean distance between the centroid of the cell of the grid and each   𝑝(𝑑𝑖,𝑗) 𝑖𝑡ℎ 𝑗𝑡ℎ
273 health centre. We employed 3 different shapes of the detection function, using different values of 
274 the shape parameter  = 10,  = 15,  = 20 (Fig.1, PA, PB and PC). Probability of reporting at 𝜎𝐴 𝜎𝐵 𝜎𝐶
275 active sampling stations was deliberately set at 1, to ensure that all the infection cases occurring at 
276 the sampling stations were recorded.
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277 By combining the three scenarios of disease incidence given by the biological process with the three 
278 scenarios of detection function, we generated nine different scenarios of reported Incidence for 
279 each cell (Ii), under a multinomial process given by [7]. For each combination scenario the response 
280 data comprised the number of reported cases per cell (Fig. 1,  to ).𝐼1A 𝐼3C
281 Preliminary manipulation of environmental layers was done using the software QGIS 82, the 
282 simulations were conducted in the statistical environment R 83, and Bayesian model fitting to the 
283 simulated data was carried out using the program JAGS 84, interfaced with R via the package rjags 85.
284 We analysed the simulated incidence data, using each of the three models described above. We 
285 used Markov Chain Monte Carlo (MCMC) algorithms (code provided in Appendix S1) to fit each of 
286 the models to the combination of environmental and incidence data. Relatively non-informative 
287 priors where chosen for all process and observation parameters and for the cells of the map relating 
288 to the latent variable. To make this a conservative test of the methodology, we employed priors 
289 wide variances. For the coefficients of the environmental covariates we chose diffuse normal priors 
290 centred at zero, corresponding to a null hypothesis of no-effect for each covariate. For the distance 
291 decay parameter σ of the detection function, we adopted a uniform prior with limits 0-1000 71 . For 
292 parameter ρ of the covariance matrix describing spatial autocorrelation in the latent covariate, we 
293 used a gamma prior (shape = 0.1, rate = 0.1). To achieve convergence, model 1 and 2 were run for 3 
294 × 104, whereas model 3 was run for 1.2 × 106 iterations.
295 Means of posterior distributions with corresponding credible intervals were obtained for each model 
296 coefficient  as well as the shape parameters of the detection function , (only relevant for models 𝛽𝑘 𝜎
297 2 and 3). For each model and each simulated scenario, we generated spatial predictions of the 
298 expected true incidence  and the latent covariate of insecticide resistance . The accuracy of each 𝑁 𝐼𝑅
299 parameter in the complete set  was examined by calculating its relative bias from the true 𝜃 = (𝑘, 𝜎)
300 underlying value, as
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𝑅𝐵𝜃 =  𝜃 ― 𝜃|𝜃| [9]
301 and by plotting the simulated vs reconstructed malaria incidence (for models 2 and 3) and  between 
302 the simulated and reconstructed insecticide resistance (for model 3)
303 RESULTS
304 The full results with posterior summaries for all model parameters are reported in the 
305 supplementary material (S2). Plots showing the relationship between the simulated and 
306 reconstructed malaria incidence and between the simulated and reconstructed insecticide 
307 resistance are also presented in supplementary material (S3). Here, we present an overview of these 
308 detailed results, by reporting on the values of relative bias |RB | for each explanatory variable, in 
309 each model, under the nine different scenarios of reported malaria incidence (Fig. 2).
310 Model 1 considered only the active sampling points, hence the single column under model 1 in Fig. 2 
311 does not include extended results pertaining to the clinic detection function (see supplementary 
312 material S2.1 for full results). Under model 1, the simulated malaria incidence was affected only by 
313 the environmental covariates (that were common to all scenarios) including insecticide resistance. 
314 Overall, the results from model 1 showed an average |RB | = 0.11 (std. dev. = 0.08). This was a 
315 persistent finding across all three simulated patterns for the latent variable (IR), with low values of 
316 relative bias arising regardless of the degree of spatial autocorrelation of the simulated insecticide 
317 resistance layer. 
318 Model 2, which considered only data from passive case detection, was less able to capture the 
319 underlying effects of predictors on the reported malaria incidence (see supplementary material S2.2 
320 for full results). The posterior means of all coefficients showed an overall average |RB | = 0.89 (std. 
321 dev. = 1.52). A pattern of increasing bias emerged in particular when considering scenarios of 
322 increasing spatial autocorrelation in the latent variable of insecticide resistance (Fig. 2). Since model 
323 2 only included the passive detection cases, the latent variable was completely missing from the list 
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324 of covariates. In scenarios ,  and , given by the same , (low spatial autocorrelation), 𝐼1A  𝐼1B  𝐼1C 𝐼𝑅1
325 the average |RB | was 0.87 (std. dev. = 1.53). Scenarios that assumed an intermediate level of spatial 
326 autocorrelation in insecticide resistance (latent variable ) generated an average |RB |  of 0.89 𝐼𝑅2
327 (std. dev. = 1.54) whereas models assuming the most spatially autocorrelated distribution of 
328 insecticide resistance ( ) generated an average |RB |  of 0.91 (std. dev. = 1.50). Contrary to the 𝐼𝑅3
329 coefficients of the process model, posteriors pertaining to the observation model were not sensitive 
330 to the different shapes of the detection function (cases PA, PB or PC). Posteriors for the parameter  𝜎
331 of the detection function were highly accurate, with absolute values of relative biases ranging from 
332 0.06 to 0.09 (Fig. 2). This model was able to partly reconstruct disease incidence, but not in areas 
333 with relatively higher levels of insecticide resistance (Fig. 3a).
334 Model 3 gave the best results in terms of estimating coefficients with low relative biases (see 
335 supplementary material S2.3 for full results). Of particular note is the fact that the parameter for the 
336 latent insecticide resistance variable  showed a low |RB | varying between 0.02 and 0.08. 𝑅𝐵𝛽𝐼𝑅
337 Overall, the average |RB | across all variables was 0.07 (std. dev. = 0.07). As with model 1, but in 
338 contrast to model 2, the magnitude of bias in estimated parameters was unrelated to the degree of 
339 spatial autocorrelation assumed in the latent variable. Similar to model 2, the parameter associated 
340 with the case detection function ( ) was estimated with good accuracy, but model 3 was more 𝜎
341 accurate in mapping case distribution (Fig. 3a, see also comparison of plots in supplementary 
342 materials S3.1 vs S3.2). Additionally, the latent distribution of the layer of insecticide resistance was 
343 accurately reconstructed using model 3 (Fig. 3b, and supplementary material S3.3). 
344 DISCUSSION
345 By analysing a wide range of plausible, simulated data sets of disease incidence and environmental 
346 variables arising from active sampling and passive case detection, we uncovered some of the 
347 disadvantages of analysing these two data types in isolation.  Additionally, we propose a novel 
348 modelling framework aimed at achieving complementarity between the two. We found that such an 
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349 integrated, spatially-explicit model, which acknowledges both active sampling and passive case 
350 detection, leads to great improvements in precision and accuracy but also enables the 
351 reconstruction of maps for the hidden variable across unsurveyed space. 
352 As expected, when modelling data arising only from active sampling, we achieved high explanatory 
353 power and relatively low bias, because the model had access to measurements of all the covariates 
354 underlying disease incidence. The model considering only data coming from passive case detection 
355 allowed us to estimate the map of malaria incidence with high accuracy. However, posterior 
356 distributions for most parameters were biased which was likely due to missing data for the 
357 important variable of insecticide resistance. This condition reflects a common situation in 
358 epidemiological studies, where passive case detection at health centres can provide a large amount 
359 of long-term data with relatively moderate effort. Our simultaneous estimation of detection 
360 functions as part of model inferences shows how to take account of imperfect reporting which is an 
361 integral characteristic of such opportunistic data 12, 27-29, 35. 
362 With our proposed 3rd model, we achieved a good synergy between depth and breadth in inference 
363 by combining the strengths of the first two models, and allowing them to compensate for each 
364 other’s limitations. In contrast to model using only passive case detection, our hybrid modelling 
365 framework allowed us to investigate the effect of all the variables (including the latent one), and to 
366 produce accurate predictive maps of the disease incidence and latent variable which were not 
367 possible with the model considering only active sampling. An important achievement of our 
368 proposed model was the capability to deal with a latent variable, regardless of its level of spatial 
369 autocorrelation. Thus, even in the absence of assumptions or any preliminary information on the 
370 spatial structure of the latent variable (e.g. whether it is akin to uncorrelated “background noise” or 
371 has a highly geography-dependent distribution) this model framework has potential to reconstruct 
372 it. 
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373 Our incremental approach showed that the gains in the accuracy of the results, moving from model 
374 1 to model 3, were a direct result of increases in the spatial complexity used by the analytical 
375 approaches. Model 1 had no explicit spatial component. Model 2 was used to generate predictions 
376 in space but it didn’t explicitly consider spatial structure in its formulation. Model 3, by including the 
377 spatial autocorrelation structure in the partly latent variable, led to the best results. 
378 Our approach to latent variables, readily generalises to processes other than insecticide resistance. 
379 We chose this particular example of a latent variable, because  has potential to impact the 𝐼𝑅
380 transmission and control of a wide range of vector-borne diseases, including malaria, but is typically 
381 labour-intensive, time-consuming and expensive to measure 86. Although WHO guidelines classify 
382 insecticide resistance in a binary way 86, the raw data from Tube test bioassays measure the % 
383 survival of cohorts of similarly aged females after a given time period of exposure to insecticide 
384 treated surfaces. Therefore, to greatly increase the inferential value acquired from such data, we 
385 treated insecticide resistance as a continuous variable ranging from 0 to 1. Our approach can be 
386 easily extended to more specific measures of insecticide resistance, such as metabolic, cuticular and 
387 behavioural resistance 53, 87, or to other types of predictor data that can be collected in the field 
388 through active sampling but are not easily obtainable via passive case detection, such as vector 
389 abundance and density. 
390 When simulating and modelling the latent variable, we made an assumption of stationarity (the 
391 autocorrelation function didn’t change in space or in time) and monotonicity (the autocorrelation 
392 always decreased with distance). These two assumptions can be plausibly relaxed extending our 
393 autocorrelation function. For example, non-stationary formulations could be achieved by expressing 
394 the rate of autocorrelation decay (ro) as a function of latitude and longitude or time. Alternatively, 
395 ro could be expressed as log-linear combination of environmental covariates. Non-monotonic 
396 formulations of the autocorrelation function could be produced for cases where periodic patterns 
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397 exist in space, but we currently see very little justification for such formulations based on biological 
398 first principles. 
399 The ability to account for reporting bias of our response variable, makes our approach easily 
400 applicable to other scenarios where an imperfect detection needs to be considered, such as citizen 
401 science data 88 or mobile phone surveillance tools 89. When modelling the detection function, we 
402 made similar assumptions (stationarity and monotonicty) to those of the autocorrelation function 
403 for the latent variable and we hypothesized the observation process was only affected by distance 
404 from health centres 10-12, 30, 32, 34. In several real-world scenarios, additional covariates of reporting 
405 probability may be involved, such as age and sex of the patient and socioeconomic factors 31, 33, 35. 
406 Borrowing fundamental concepts from Distance sampling 47, we assumed that at zero distance the 
407 probability of reporting the disease was 100%, however asymptomatic disease in apparently healthy 
408 people is common 66, 90, and would not be observed in clinical data.  Thus, incomplete detection at 
409 zero distance (based on additional calibration data on the frequency of asymptomatic cases) must be 
410 considered 91.  Finally, human mobility is unlikely to be strictly related to Euclidean distance (a third 
411 implicit assumption of our detection function), so it may be preferable to use the distance according 
412 to road network 6, when applying this model to real data. Global digital layers quantifying underlying 
413 “landscape resistance ”, describe the travel time between any two points on the globe,  based on data 
414 such as road density, terrain morphology and an political borders 36, could be easily included in a 
415 spatially explicit epidemiological model such as ours 92. For all of these reasons, we suggest that 
416 preliminary analysis using pilot data and focussing only on modelling the detection probability 
417 should be carried out before integrating it into the final model.
418 Our likelihood could be deployed using either a Bayesian or a frequentist setting. It is likely that in 
419 real life, most epidemiological data sets will be accompanied by sufficient expert opinion to lead to 
420 influential priors, hence we have illustrated using a Bayesian approach. However, we did not assume 
421 the existence of expert opinion here, because we were seeking to construct a conservative test of 
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422 our methods. The models presented here (in particular our model 3, using both data types) require a 
423 high computational effort (see supplementary material for details). Notwithstanding their 
424 theoretical simplicity, the need to take spatial structure into account with a large dataset slows 
425 down the Bayesian MCMC inference. Other model fitting approaches such as the Integrated Nested 
426 Laplace approximation (INLA)93, may prove capable of providing similarly accurate results but with 
427 faster processing 94.
428 In quantitative ecology, data simulation, by generating random realisations from stochastic 
429 processes described by a series of distributional statements, is exceedingly useful 71. Although 
430 simulated studies are not guaranteed to be the same as a real epidemiological system, they allow 
431 objective validation of proposed frameworks on a wide range of plausible scenarios, easily adaptable 
432 to other epidemiological studies. Although our simulation was borrowing its settings from a study 
433 specifically looking at malaria, we demonstrated its applicability on a broad range of contrasting 
434 scenarios. Therefore we believe that such a framework can successfully work under different 
435 epidemiological systems, where a combination of large-scale but opportunistic data are collected at 
436 the same time as conducting a small number of localised  scientific surveys.
437 The strength of our proposed analytical approach lies in its ability to use distinct solutions, such as 
438 latent process modelling and spatially autoregressive modelling, in a fully integrated framework. In 
439 particular, we demonstrated how active sampling and passive case detection, that have so far been 
440 considered independently in the context of spatial epidemiology, can be used simultaneously and 
441 complimentarily in a package where the strength of one compensates for the drawback of the other. 
442 Our method shows promise for complex spatial epidemiology studies, by allowing different parts of 
443 the model to glean information from different types of data. Such egalitarian and complementary 
444 use of two, or more data types, can be extended to make use of digital or hard copy primary care 
445 records, irrespective of the sophistication of the health provision systems, the density of the human 
446 population, or the nature of the disease. 
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694 FIGURE CAPTIONS 
695 Figure 1 – Location of active sampling sites, simulation of reported malaria reported incidence (I1A, 
696 …, I3C) under 3 scenarios of insecticide resistance (IR1, IR2, IR3) and 3 scenarios of reporting 
697 probability as a function of distance from health centres (PA, PB, PC).
698 Figure 2 – Visual summary of results of the three Bayesian models of reported malaria incidence (I ) 
699 under different simulated scenarios of insecticide resistance spatial patterns (IR) and probability of 
700 reporting at health centres (P ). Model 1 used only active sampling data from some localised surveys, 
701 model 2 only passive case detections at health centres, model 3 combined both data sources 
702 together. The colour scale refers to the absolute values of the relative bias between the simulated 
703 coefficients of the variables involved in the biological process (1 to 6), or the shape parameter of the 
704 detection function (7), and the estimate of the same coefficient obtained by the mean of Markov 
705 Chain Monte Carlo (MCMC) posterior distributions. (•) indicates that the simulated coefficient is 
706 within the corresponding 95% posterior credibile interval, (×) indicates that it falls outside.
707 Figure 3 – Reconstructions of a simulated scenario of a) malaria incidence and b) insecticide 
708 resistance using Bayesian models. Figure refers to scenario 3B (see Fig. 1), with a high level of 
709 insecticide resistance spatial autocorrelation and an intermediate shape of the detection function. 
710 Model 1 used only active sampling data from a small set of localised surveys, model 2 only passive 
711 case detections at health centres, model 3 combined both data sources together.
712
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Supplementary material S1
Nelli L., Ferguson H.M., Matthiopoulos J.
Achieving depth and breadth in spatial models of vector-borne diseases: an integrated framework 
for active survey and passive surveillance data.
The following R scripts are used to generate the simulated dataset and to run the three models 
presented in the paper. Note that in the paper we presented 9 different scenarios, whereas here we 
are simulating only 1 scenario with an intermediate level of spatial autocorrelation of insecticide 
resistance (ro=0.7, see L 57) and an intermediate scenario of detectability (sigma=15, see L 126).
Also, note that the dataset provided as supplementary material is a subset of the entire data that we 
analysed in the paper, therefore some difference in the final results might be expected. 
For constant updates on this scripts, please visit https://lucanelli.wordpress.com/r-codes.
1 R code for data simulation and models
2 library(rgdal)
3 library(mvtnorm)
4 library(raster)
5 library(rgeos)
6 library(R2jags)
7 library(jagstools)
8
9 #read the grid in shapefile format. Please find it as paper's supplementary material 
10 "grid.shp"
11 grid<-readOGR("your.folder.path","grid", GDAL1_integer64_policy=T)
12
13 # set the distance from clinics=0 in active sampling points (to set probability of reporting 
14 as 1)
15 grid$dist_1[grid$sampling==1] <- 0
16 grid$dist_2[grid$sampling==1] <- 0
17 grid$dist_3[grid$sampling==1] <- 0
18 grid$dist_4[grid$sampling==1] <- 0
19 grid$dist_5[grid$sampling==1] <- 0
20 grid$dist_6[grid$sampling==1] <- 0
21 grid$dist_7[grid$sampling==1] <- 0
22 grid$dist_8[grid$sampling==1] <- 0
23
24
25 # ############################################
26 # #### - simulate Insecticide Resistance - ###
27 # ############################################
28
29 # function to make a distance matrix (side*side) 2D array  
30 dist.matrix <- function(side)
31 {
32   row.coords <- rep(1:side, times=side)
33   col.coords <- rep(1:side, each=side)
34   row.col <- data.frame(row.coords, col.coords)
35   D <- dist(row.col, method="euclidean", diag=TRUE, upper=TRUE)
36   D <- as.matrix(D)
37   return(D)
38 }
39
40
41 # function to simulate an autocorrelated surface, with exponential decay given by ro
42 cor.surface <- function(side, global.mu, ro)
43 {
44   D <- dist.matrix(side)
45   # scaling the distance matrix by the exponential decay
46   SIGMA <- exp(-ro*D)
47   mu <- rep(global.mu, times=side*side)
48   # sampling from the multivariate normal distribution
49   M <- matrix(nrow=side, ncol=side)
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50   M[] <- rmvnorm(1, mu, SIGMA)
51   return(M)
52 }
53
54 # parameters 
55 side <- max(c(grid@bbox[1,2]-grid@bbox[1,1],grid@bbox[2,2]-grid@bbox[2,1]))/1000 # Arena 
56 dimension (take the maximum extension of the bounding box of the grid, in Km)
57 global.mu <- 0
58 ro <- 0.7 #note that here I'm simulating only the intermediate scenario.
59
60 # simulating the autocorrelated raster
61 set.seed(1)
62 ir <- cor.surface(side = side, ro = ro, global.mu = global.mu) #this may take a lot (up to few 
63 hours, depending on the computation power)
64 image(ir) # have a look
65
66 # now transform it into a raster and assign it to the cells
67 ir.raster <-raster(ir)
68 extent(ir.raster) <- (grid@bbox)
69 plot(ir.raster)
70 summary(ir.raster)
71 grid$IR<-(extract(ir.raster, gCentroid(grid,byid=TRUE), na.rm = T, small = T, df = T))$layer
72 summary(grid$IR)
73
74
75 ##################################################
76 #### - Simulate the dataset of malaria cases - ###
77 ##################################################
78
79 #scaling environmentalvariables
80 scale2 <- function(x) {
81   sdx <- sqrt(var(x))
82   meanx <- mean(x)
83   return((x - meanx)/sdx)
84 }
85
86 grid$NDVI<-scale2(grid$NDVI)
87 grid$RAIN<-scale2(as.integer(grid$RAIN))
88 grid$TEMP<-scale2(as.integer(grid$TEMP))
89 grid$HUM<-scale2(grid$HUM)
90
91
92 # set the simulated coefficients and create the matrix of coefficients 'a'
93 sim.intercept     <- 2.90
94 sim.beta.NDVI     <- 0.30
95 sim.beta.RAIN     <- 0.20
96 sim.beta.TEMP     <- 0.25     
97 sim.beta.HUM      <- 0.20
98 sim.beta.IR       <- 0.50 
99
100 a<-rbind(sim.intercept,
101          sim.beta.NDVI,
102          sim.beta.RAIN,
103          sim.beta.TEMP,
104          sim.beta.HUM,
105          sim.beta.IR)
106
107 #Create a the covariate matrix 'x'
108 x<- matrix(c(rep(1,length(grid)),                            
109              grid$NDVI, 
110              grid$RAIN, 
111              grid$TEMP, 
112              grid$HUM,
113              grid$IR),
114            nrow=length(grid))
115
116 #generate a poisson rates L
117 grid$L<- as.vector(x %*% a)
118
119 #generate true incidence N (number of malaria cases under the biological process)
120 grid$lambda<-exp(grid$L)
121 set.seed(1)
122 grid$N<-rpois(length(grid),grid$lambda)
123
124 # set probability of reporting (Pd) at each clinic, according to a half normal function with 
125 sigma=15
126 HN<-function (x,si) {exp(-(x^2)/(2*sigma^2))}
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127 sigma<-15
128
129 grid$Pd1<-HN(grid$dist_1,si)
130 grid$Pd2<-HN(grid$dist_2,si)
131 grid$Pd3<-HN(grid$dist_3,si)
132 grid$Pd4<-HN(grid$dist_4,si)
133 grid$Pd5<-HN(grid$dist_5,si)
134 grid$Pd6<-HN(grid$dist_6,si)
135 grid$Pd7<-HN(grid$dist_7,si)
136 grid$Pd8<-HN(grid$dist_8,si)
137
138 # set the overall probability of not reporting any case at all (Q)
139 grid$Q<-(1-grid$Pd1)*
140   (1-grid$Pd2)*
141   (1-grid$Pd3)*
142   (1-grid$Pd4)*
143   (1-grid$Pd5)*
144   (1-grid$Pd6)*
145   (1-grid$Pd7)*
146   (1-grid$Pd8)
147
148 # generate the reported incidence (I) under the observation process
149 n.clinics<-8
150 grid$I<-matrix(nrow = length(grid), ncol = n.clinics+1)
151
152 for (i in 1:length(grid)) {
153   set.seed(1)
154   grid$I[i,]<-rmultinom(1, grid$N[i], cbind(grid$Pd1[i],
155                                             grid$Pd2[i],
156                                             grid$Pd3[i],
157                                             grid$Pd4[i],
158                                             grid$Pd5[i],
159                                             grid$Pd6[i],
160                                             grid$Pd7[i],
161                                             grid$Pd8[i],
162                                             grid$Q[i]))
163 }
164
165 # total reported cases at each cell
166 grid$total.reported.cases<-rowSums(grid$I[,1:n.clinics])
167
168 # reported cases from clinics only (set NA in active sampling cells)
169 grid$incidence.clinics<-grid$I
170 grid$incidence.clinics[grid$sampling==1]<-NA
171
172
173 #################################################
174 ###### Model 1 - active sampling only    ########
175 #################################################
176
177 #subset the data, only active sampling sites
178 grid.sub<-subset(grid, sampling==1)
179
180 #Jags model
181 model.1<-function() {
182   # Priors
183   alpha          ~ dnorm(0,0.001)   
184   beta.NDVI      ~ dnorm(0,0.001)   
185   beta.RAIN      ~ dnorm(0,0.001)   
186   beta.TEMP      ~ dnorm(0,0.001)   
187   beta.HUM       ~ dnorm(0,0.001)  
188   beta.IR        ~ dnorm(0,0.001)   
189   si             ~ dgamma(0.01, 0.01)
190   
191   for (i in 1:n) {
192     
193     count[i]~dbin(1,raw.count[i])
194     
195     raw.count[i]~dpois(lambda[i])  
196     
197     log(lambda[i]) <- alpha + 
198       beta.NDVI*NDVI[i] + 
199       beta.RAIN*RAIN[i] + 
200       beta.TEMP*TEMP[i]+ 
201       beta.HUM*HUM[i]+
202       beta.IR*IR[i]+eps[i]
203     
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204     eps[i]~dnorm(0, si)
205   }
206   
207 }
208
209
210 params<-c("alpha","beta.NDVI","beta.RAIN","beta.TEMP","beta.HUM","beta.IR")
211 n.iterations<-2000  
212
213 jags.data.survey <- list (count=grid.sub$total.reported.cases, 
214                           NDVI=grid.sub$NDVI,
215                           RAIN=grid.sub$RAIN,
216                           TEMP=grid.sub$TEMP,
217                           HUM=grid.sub$HUM,
218                           IR=grid.sub$IR,
219                           n=length(grid.sub))
220
221
222 jags.out.survey<-jags(data=jags.data.survey,
223                                model.file=model.1,
224                                n.chains= 3,
225                                n.iter=n.iterations,
226                                parameters.to.save=params)
227
228
229 ##################################################
230 ###### Model 2 - passive case detection   ########
231 ##################################################
232
233
234 model.2<-function() {
235   # Priors
236   alpha        ~ dnorm(0,0.0001)
237   beta.NDVI    ~ dnorm(0,0.0001)
238   beta.RAIN    ~ dnorm(0,0.0001)
239   beta.TEMP    ~ dnorm(0,0.0001)
240   beta.HUM     ~ dnorm(0,0.0001)
241   sigma        ~ dunif(0,100)
242   si           ~ dgamma(0.01, 0.01)
243   
244   
245   # Likelihood
246   
247   for (i in 1:n) {
248     
249     counts[i,1:8]~dmulti(probs[i,1:8],reported.cases[i]) 
250     
251     probs[i,1]<-exp(-(dist_1[i]*dist_1[i])/(2*sigma*sigma))
252     probs[i,2]<-exp(-(dist_2[i]*dist_2[i])/(2*sigma*sigma))
253     probs[i,3]<-exp(-(dist_3[i]*dist_3[i])/(2*sigma*sigma))
254     probs[i,4]<-exp(-(dist_4[i]*dist_4[i])/(2*sigma*sigma))
255     probs[i,5]<-exp(-(dist_5[i]*dist_5[i])/(2*sigma*sigma))
256     probs[i,6]<-exp(-(dist_6[i]*dist_6[i])/(2*sigma*sigma))
257     probs[i,7]<-exp(-(dist_7[i]*dist_7[i])/(2*sigma*sigma))
258     probs[i,8]<-exp(-(dist_8[i]*dist_8[i])/(2*sigma*sigma))
259     
260     reported.cases[i]~dbinom(overall_prob[i], true.incidence[i])
261     
262     overall_prob[i]<-1-Q[i]
263     
264     Q[i] <- q1[i]*q2[i]*q3[i]*q4[i]*q5[i]*q6[i]*q7[i]*q8[i]
265     q1[i] <- 1-probs[i,1]
266     q2[i] <- 1-probs[i,2]
267     q3[i] <- 1-probs[i,3]
268     q4[i] <- 1-probs[i,4]
269     q5[i] <- 1-probs[i,5]
270     q6[i] <- 1-probs[i,6]
271     q7[i] <- 1-probs[i,7]
272     q8[i] <- 1-probs[i,8]
273     
274     true.incidence[i]~dpois(lambda[i])
275     
276     log(lambda[i]) <- alpha + beta.NDVI*NDVI[i] +
277       beta.RAIN*RAIN[i] +
278       beta.TEMP*TEMP[i] +
279       beta.HUM*HUM[i] + eps[i]
280     
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281     eps[i]~dnorm(0, si)
282   }
283 }
284
285
286 params<-c("alpha","beta.NDVI","beta.RAIN","beta.TEMP","beta.HUM", "sigma","true.incidence")
287
288 inits <- function(){list (true.incidence = rowSums(counts[,1:8]))}
289
290 n.iterations<-2000
291
292
293 jags.data.clinics <-list (counts=grid$incidence.clinics[,1:8],
294                           NDVI=grid$NDVI,
295                           RAIN=grid$RAIN,
296                           TEMP=grid$TEMP,
297                           HUM=grid$HUM,
298                           dist_1=grid$dist_1,
299                           dist_2=grid$dist_2,
300                           dist_3=grid$dist_3,
301                           dist_4=grid$dist_4,
302                           dist_5=grid$dist_5,
303                           dist_6=grid$dist_6,
304                           dist_7=grid$dist_7,
305                           dist_8=grid$dist_8,
306                           n=length(grid))
307
308 jags.out.clinics<-jags(data=jags.data.clinics,
309                                 model.file=model.2,
310                                 inits=inits,
311                                 n.chains=3,
312                                 n.iter=n.iterations,
313                                 parameters.to.save=params)
314
315 ############################################################
316 ###### Model 3 - active and passive case together   ########
317 ############################################################
318
319
320 DM<-gDistance(gCentroid(grid,byid=TRUE),byid=T)/1000 # calculate distances for covariance 
321 matrix
322
323 model.3<-function() {
324   # Priors
325   alpha        ~ dnorm(0,0.0001)
326   beta.NDVI    ~ dnorm(0,0.0001)
327   beta.RAIN    ~ dnorm(0,0.0001)
328   beta.TEMP    ~ dnorm(0,0.0001)
329   beta.HUM     ~ dnorm(0,0.0001)
330   beta.IR      ~ dnorm(0,0.0001)
331   si           ~ dgamma(0.01, 0.01)
332   sigma        ~ dunif(0, 100)
333   ro           ~ dgamma(0.1,0.1)
334   global.mu    ~ dnorm(0,0.0001)
335   
336   
337   # Likelihood
338   
339   for (i in 1:n) {
340     
341     counts[i,1:8]~dmulti(probs[i,1:8],reported.cases[i]) 
342     
343     probs[i,1]<-exp(-(dist_1[i]*dist_1[i])/(2*sigma*sigma))
344     probs[i,2]<-exp(-(dist_2[i]*dist_2[i])/(2*sigma*sigma))
345     probs[i,3]<-exp(-(dist_3[i]*dist_3[i])/(2*sigma*sigma))
346     probs[i,4]<-exp(-(dist_4[i]*dist_4[i])/(2*sigma*sigma))
347     probs[i,5]<-exp(-(dist_5[i]*dist_5[i])/(2*sigma*sigma))
348     probs[i,6]<-exp(-(dist_6[i]*dist_6[i])/(2*sigma*sigma))
349     probs[i,7]<-exp(-(dist_7[i]*dist_7[i])/(2*sigma*sigma))
350     probs[i,8]<-exp(-(dist_8[i]*dist_8[i])/(2*sigma*sigma))
351     
352     reported.cases[i]~dbinom(overall_prob[i], true.incidence[i])
353     
354     overall_prob[i]<-1-Q[i]
355     
356     Q[i] <- q1[i]*q2[i]*q3[i]*q4[i]*q5[i]*q6[i]*q7[i]*q8[i]
357     q1[i] <- 1-probs[i,1]
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358     q2[i] <- 1-probs[i,2]
359     q3[i] <- 1-probs[i,3]
360     q4[i] <- 1-probs[i,4]
361     q5[i] <- 1-probs[i,5]
362     q6[i] <- 1-probs[i,6]
363     q7[i] <- 1-probs[i,7]
364     q8[i] <- 1-probs[i,8]
365     
366     true.incidence[i]~dpois(lambda[i])
367     
368     log(lambda[i]) <- alpha + beta.NDVI*NDVI[i] +
369       beta.IR*IR[i]+
370       beta.RAIN*RAIN[i] +
371       beta.TEMP*TEMP[i] +
372       beta.HUM*HUM[i] + eps[i]
373     
374     eps[i]~dnorm(0, si)
375     
376     
377     for(j in 1:n)
378     {
379       # turning the distance matrix to covariance matrix
380       C.w[i,j] <- exp(-ro*D[i,j])  
381     }
382     
383     # turning covariances into precisions
384     P.w[i,i] <- inverse(C.w[i,i])
385     mu[i] <- global.mu
386     IR[i] ~ dmnorm(mu[i], P.w[i,i])
387     
388   }
389 }
390
391
392
393 n.iterations<-20000   
394
395 params<-c("alpha","beta.NDVI","beta.RAIN","beta.HUM", "beta.TEMP", "beta.IR", "sigma","ro", 
396 "global.mu","true.incidence","IR")
397
398 grid$IR.NA<-grid$IR
399 grid$IR.NA[grid$sampling==0]<-NA   #set NA in all the cells but those of sampling points 
400 counts=grid$I[,1:8]
401 inits <- function(){list (true.incidence = rowSums(counts[,1:8]))}
402
403 index<-c(1:nrow(grid))[-which(grid$sampling==1)]     # create an index for NAs cells (that is, 
404 all but the 12 sampling stations)
405
406 jags.data.both <- list (counts=grid$I[,1:8],
407                         NDVI=grid$NDVI,
408                         RAIN=grid$RAIN,
409                         TEMP=grid$TEMP,
410                         HUM=grid$HUM,
411                         dist_1=grid$dist_1,
412                         dist_2=grid$dist_2,
413                         dist_3=grid$dist_3,
414                         dist_4=grid$dist_4,
415                         dist_5=grid$dist_5,
416                         dist_6=grid$dist_6,
417                         dist_7=grid$dist_7,
418                         dist_8=grid$dist_8,
419                         IR=grid$IR.NA,
420                         n=length(grid),
421                         nn=length(index),
422                         index=index,
423                         D=DM)
424
425 jags.out.both<-jags(data=jags.data.both,           #this will take a lot.
426                              model.file=model.3,
427                              n.chains=3,
428                              inits=inits,
429                              n.iter=n.iterations,
430                              # n.thin=1, 
431                              parameters.to.save=params)
432
433
434
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435
436 #######################
437 ## RESULTS - MODEL 1 ##
438 #######################
439
440 # results of model 1
441
442 mu.model1<-jagsresults(x=jags.out.survey, params=c("alpha","beta.HUM","beta.NDVI","beta.RAIN", 
443 "beta.TEMP","beta.IR", "sigma"))[,1]
444 sd.model1<-jagsresults(x=jags.out.survey, params=c("alpha","beta.HUM","beta.NDVI","beta.RAIN", 
445 "beta.TEMP","beta.IR", "sigma"))[,2]
446 LCI.model1<-jagsresults(x=jags.out.survey, 
447 params=c("alpha","beta.HUM","beta.NDVI","beta.RAIN", "beta.TEMP","beta.IR", "sigma"))[,3]
448 UCI.model1<-jagsresults(x=jags.out.survey, 
449 params=c("alpha","beta.HUM","beta.NDVI","beta.RAIN", "beta.TEMP","beta.IR", "sigma"))[,7]
450 Rhat.model1<-jagsresults(x=jags.out.survey, 
451 params=c("alpha","beta.HUM","beta.NDVI","beta.RAIN", "beta.TEMP","beta.IR", "sigma"))[,8]
452 n.eff.model1<-jagsresults(x=jags.out.survey, 
453 params=c("alpha","beta.HUM","beta.NDVI","beta.RAIN", "beta.TEMP","beta.IR", "sigma"))[,9]
454
455
456 res.model1<-data.frame(mu.vect=mu.model1,
457                         sd.vect=sd.model1,
458                         LCI=LCI.model1,
459                         UCI=UCI.model1,
460                         Rhat=Rhat.model1,
461                         n.eff=n.eff.model1)
462
463 res.model1
464
465
466 #######################
467 ## RESULTS - MODEL 2 ##
468 #######################
469
470 # results of model 2
471
472 mu.model2<-jagsresults(x=jags.out.clinics, 
473 params=c("alpha","beta.HUM","beta.NDVI","beta.RAIN", "beta.TEMP", "sigma"))[,1]
474 sd.model2<-jagsresults(x=jags.out.clinics, 
475 params=c("alpha","beta.HUM","beta.NDVI","beta.RAIN", "beta.TEMP", "sigma"))[,2]
476 LCI.model2<-jagsresults(x=jags.out.clinics, 
477 params=c("alpha","beta.HUM","beta.NDVI","beta.RAIN", "beta.TEMP", "sigma"))[,3]
478 UCI.model2<-jagsresults(x=jags.out.clinics, 
479 params=c("alpha","beta.HUM","beta.NDVI","beta.RAIN", "beta.TEMP", "sigma"))[,7]
480 Rhat.model2<-jagsresults(x=jags.out.clinics, 
481 params=c("alpha","beta.HUM","beta.NDVI","beta.RAIN", "beta.TEMP", "sigma"))[,8]
482 n.eff.model2<-jagsresults(x=jags.out.clinics, 
483 params=c("alpha","beta.HUM","beta.NDVI","beta.RAIN", "beta.TEMP", "sigma"))[,9]
484
485
486 res.model2<-data.frame(mu.vect=mu.model2,
487                        sd.vect=sd.model2,
488                        LCI=LCI.model2,
489                        UCI=UCI.model2,
490                        Rhat=Rhat.model2,
491                        n.eff=n.eff.model2)
492
493 res.model2
494
495 # reconstruction of true incidence from model 2
496
497 grid$rec.incid.model2<-jags.out.clinics$BUGSoutput$mean$true.incidence
498
499 # transform into a raster (for nicer plotting)
500 r<-raster()
501 extent(r) <- extent(grid)
502 rec.incid.model2.rast<-rasterize(grid,r,'rec.incid.model2')
503 N.rast<-rasterize(grid,r,'N')
504
505 par(mfrow=c(1, 3))
506 plot(N.rast,  main ="True Incidence")
507 plot(rec.incid.model2.rast, main ="Reconstructed Incidence")
508 plot(grid$rec.incid.model2~grid$N, main="True vs Reconstructed Incidence")
509 par(mfrow=c(1, 1))
510
511
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512 #######################
513 ## RESULTS - MODEL 3 ##
514 #######################
515
516 # results of model 3
517
518 mu.model3<-jagsresults(x=jags.out.both, params=c("alpha","beta.HUM","beta.NDVI","beta.RAIN", 
519 "beta.TEMP","beta.IR", "sigma"))[,1]
520 sd.model3<-jagsresults(x=jags.out.both, params=c("alpha","beta.HUM","beta.NDVI","beta.RAIN", 
521 "beta.TEMP","beta.IR", "sigma"))[,2]
522 LCI.model3<-jagsresults(x=jags.out.both, params=c("alpha","beta.HUM","beta.NDVI","beta.RAIN", 
523 "beta.TEMP","beta.IR", "sigma"))[,3]
524 UCI.model3<-jagsresults(x=jags.out.both, params=c("alpha","beta.HUM","beta.NDVI","beta.RAIN", 
525 "beta.TEMP","beta.IR", "sigma"))[,7]
526 Rhat.model3<-jagsresults(x=jags.out.both, params=c("alpha","beta.HUM","beta.NDVI","beta.RAIN", 
527 "beta.TEMP","beta.IR", "sigma"))[,8]
528 n.eff.model3<-jagsresults(x=jags.out.both, 
529 params=c("alpha","beta.HUM","beta.NDVI","beta.RAIN", "beta.TEMP","beta.IR", "sigma"))[,9]
530
531
532 res.model3<-data.frame(mu.vect=mu.model3,
533                        sd.vect=sd.model3,
534                        LCI=LCI.model3,
535                        UCI=UCI.model3,
536                        Rhat=Rhat.model3,
537                        n.eff=n.eff.model3)
538
539 res.model3
540
541 # reconstruction of true incidence from model 3
542
543 grid$rec.incid.model3<-jags.out.both$BUGSoutput$mean$true.incidence
544
545 # transform into a raster (for nicer plotting)
546 r<-raster()
547 extent(r) <- extent(grid)
548 rec.incid.model3.rast<-rasterize(grid,r,'rec.incid.model3')
549
550 par(mfrow=c(1, 3))
551 plot(N.rast,  main ="True Incidence")
552 plot(rec.incid.model3.rast, main ="Reconstructed Incidence")
553 plot(grid$rec.incid.model3~grid$N, main="True vs Reconstructed Incidence")
554 par(mfrow=c(1, 1))
555
556
557 # reconstruction of insecticide resistance from model 3
558
559 grid$rec.InsRes.model3<-jags.out.both$BUGSoutput$mean$IR
560
561 # transform into a raster (for nicer plotting)
562 r<-raster()
563 extent(r) <- extent(grid)
564 rec.InsRes.model3.rast<-rasterize(grid,r,'rec.InsRes.model3')
565
566 par(mfrow=c(1, 3))
567 plot(ir.raster, col=rev(heat.colors(255)),  main ="True insecticide resistance")
568 plot(rec.InsRes.model3.rast,col=rev(heat.colors(255)), main ="Reconstructed insecticide 
569 resistance")
570 plot(grid$rec.InsRes.model3~grid$IR, main="True vs Reconstructed insecticide resistance")
571 par(mfrow=c(1, 1))
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Supplementary material S2
Nelli L., Ferguson H.M., Matthiopoulos J.
Achieving depth and breadth in spatial models of vector-borne diseases: an integrated framework 
for active survey and passive surveillance data.
S2.1 – Result of Bayesian models of reported malaria incidence under different scenarios of 
insecticide resistance patterns. The table shows results of model 1, which considered only active 
sampling data from some localised surveys. θ: simulated coefficient, : mean of posterior θ
distribution, CI: credible interval, RB: relative bias.
Scenario I1A=I1B=I1C
Variable θ  (95% CI)𝛉 RB
Intercept 2.90 2.89 (2.82, 2.95) -0.01
HUM 0.20 0.24 (0.14, 0.34) 0.21
NDVI 0.30 0.27 (0.20, 0.33) -0.11
RAIN 0.20 0.22 (0.14, 0.31) 0.12
TEMP 0.25 0.21 (0.08, 0.34) -0.18
IR 0.50 0.49 (0.44, 0.55) -0.01
Scenario I2A=I2B=I2C
Variable θ  (95% CI)𝛉 RB
Intercept 2.90 2.90 (2.83, 2.96) 0.00
HUM 0.20 0.24 (0.14, 0.34) 0.19
NDVI 0.30 0.29 (0.21, 0.36) -0.05
RAIN 0.20 0.18 (0.09, 0.27) -0.10
TEMP 0.25 0.19 (0.05, 0.32) -0.26
IR 0.50 0.44 (0.37, 0.50) -0.13
Scenario I3A=I3B=I3C
Variable θ  (95% CI)𝛉 RB
Intercept 2.90 2.86 (2.79, 2.92) -0.01
HUM 0.20 0.15 (0.04, 0.26) -0.26
NDVI 0.30 0.32 (0.24, 0.39) 0.06
RAIN 0.20 0.21 (0.11, 0.32) 0.06
TEMP 0.25 0.30 (0.15, 0.47) 0.22
IR 0.50 0.52 (0.44, 0.60) 0.04
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S2.2 – Result of Bayesian models of reported malaria incidence under different scenarios of 
insecticide resistance patterns and detectability at health centres. The table shows results of model 
2, which considered only passive case detections at health centres. σ: shape parameter oh half-
normal detection function, θ: simulated coefficient, : mean of posterior distribution, CI: credible θ
interval, RB: relative bias.
Scenario I1A Scenario I1B Scenario I1C
Variable θ  (95% CI)𝛉 RB θ  (95% CI)𝛉 RB θ  (95% CI)𝛉 RB
Intercept 2.90 2.53 (2.51, 2.55) -0.13 2.90 2.51 (2.49, 2.53) -0.13 2.90 2.48 (2.46, 2.50) -0.15
HUM 0.20 1.01 (0.99, 1.04) 4.07 0.20 1.07 (1.04, 1.09) 4.33 0.20 1.08 (1.05, 1.10) 4.38
NDVI 0.30 0.26 (0.24, 0.28) -0.13 0.30 0.24 (0.22, 0.26) -0.20 0.30 0.24 (0.22, 0.26) -0.19
RAIN 0.20 0.30 (0.28, 0.33) 0.51 0.20 0.30 (0.27, 0.32) 0.48 0.20 0.33 (0.30, 0.35) 0.63
TEMP 0.25 0.25 (0.22, 0.27) -0.02 0.25 0.23 (0.20, 0.25) -0.10 0.25 0.24 (0.22, 0.26) -0.03
σ 10.00 10.35 (9.99, 10.39) 0.03 15.00 14.14 (14.00, 14.19) -0.06 20.00 21.74 (19.64, 21.83) 0.09
Scenario I2A Scenario I2B Scenario I2C
Variable θ  (95% CI)𝛉 RB θ  (95% CI)𝛉 RB θ  (95% CI)𝛉 RB
Intercept 2.90 2.50 (2.48, 2.52) -0.14 2.90 2.50 (2.48, 2.52) -0.14 2.90 2.48 (2.46, 2.50) -0.14
HUM 0.20 1.10 (1.07, 1.13) 4.51 0.20 1.04 (1.02, 1.07) 4.21 0.20 1.04 (1.02, 1.07) 4.20
NDVI 0.30 0.24 (0.22, 0.26) -0.19 0.30 0.24 (0.22, 0.26) -0.19 0.30 0.22 (0.02, 0.24) -0.26
RAIN 0.20 0.33 (0.30, 0.35) 0.63 0.20 0.31 (0.29, 0.34) 0.57 0.20 0.28 (0.26, 0.30) 0.40
TEMP 0.25 0.20 (0.17, 0.22) -0.21 0.25 0.23 (0.21, 0.26) -0.07 0.25 0.23 (0.21, 0.26) -0.07
σ 10.00 9.46 (9.42, 9.50) -0.05 15.00 14.93 (14.87, 15.02) 0.00 20.00 20.36 (19.27, 20.45) 0.02
Scenario I3A Scenario I3B Scenario I3C
Variable θ  (95% CI)𝛉 RB θ  (95% CI)𝛉 RB θ  (95% CI)𝛉 RB
Intercept 2.90 2.42 (2.40, 2.45) -0.16 2.90 2.42 (2.40, 2.43) -0.17 2.90 2.39 (2.37, 2.41) -0.18
HUM 0.20 1.05 (1.02, 1.08) 4.25 0.20 1.05 (1.02, 1.07) 4.25 0.20 1.04 (1.02, 1.07) 4.22
NDVI 0.30 0.24 (0.22, 0.26) -0.19 0.30 0.23 (0.21, 0.25) -0.23 0.30 0.22 (0.20, 0.24) -0.28
RAIN 0.20 0.31 (0.29, 0.34) 0.56 0.20 0.26 (0.24, 0.29) 0.31 0.20 0.26 (0.23, 0.28) 0.29
TEMP 0.25 0.14 (0.11, 0.16) -0.45 0.25 0.16 (0.14, 0.19) -0.34 0.25 0.16 (0.14, 0.18) -0.36
σ 10.00 9.84 (9.80, 10.01) -0.02 15.00 14.59 (14.53, 15.65) -0.03 20.00 19.32 (19.23, 20.41) -0.03
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S2.3 – Result of Bayesian models of reported malaria incidence under different scenarios of 
insecticide resistance patterns and detectability at health centres. The table shows results of model 
3, which considered both active surveys and passive case detections at health centres. σ: shape 
parameter oh half-normal detection function, θ: simulated coefficient, : mean of posterior θ
distribution, CI: credible interval, RB: relative bias.
Scenario I1A Scenario I1B Scenario I1C
Variable θ  (95% CI)𝛉 RB θ  (95% CI)𝛉 RB θ  (95% CI)𝛉 RB
Intercept 2.90 2.91 (2.87, 2.96) 0.00 2.90 2.92 (2.87, 2.96) 0.01 2.90 2.90 (2.85, 2.94) 0.00
HUM 0.20 0.17 (0.15, 0.19) -0.16 0.20 0.17 (0.16, 0.19) -0.13 0.20 0.20 (0.18, 0.21) -0.02
NDVI 0.30 0.30 (0.29, 0.32) 0.01 0.30 0.31 (0.29, 0.32) 0.02 0.30 0.30 (0.29, 0.32) 0.01
RAIN 0.20 0.18 (0.16, 0.20) -0.12 0.20 0.17 (0.15, 0.19) -0.14 0.20 0.21 (0.19, 0.23) 0.03
TEMP 0.25 0.24 (0.22, 0.26) -0.04 0.25 0.22 (0.20, 0.24) -0.11 0.25 0.24 (0.22, 0.26) -0.05
IR 0.50 0.47 (0.45, 0.48) -0.07 0.50 0.48 (0.46, 0.49) -0.04 0.50 0.48 (0.46, 0.49) -0.04
σ 10.00 10.37 (10.00, 10.41) 0.04 15.00 14.80 (14.74, 15.85) -0.05 20.00 22.58 (22.48, 22.67) 0.13
Scenario I2A Scenario I2B Scenario I2C
Variable θ  (95% CI)𝛉 RB θ  (95% CI)𝛉 RB θ  (95% CI)𝛉 RB
Intercept 2.90 2.92 (2.87, 2.96) 0.01 2.90 2.94 (2.90, 2.97) 0.01 2.90 2.92 (2.87, 2.97) 0.01
HUM 0.20 0.23 (0.21, 0.25) 0.16 0.20 0.16 (0.14, 0.18) -0.22 0.20 0.16 (0.14, 0.17) -0.22
NDVI 0.30 0.27 (0.25, 0.28) -0.11 0.30 0.30 (0.28, 0.31) 0.00 0.30 0.29 (0.27, 0.30) -0.04
RAIN 0.20 0.16 (0.14, 0.18) -0.19 0.20 0.18 (0.16, 0.20) -0.09 0.20 0.15 (0.13, 0.17) -0.23
TEMP 0.25 0.18 (0.16, 0.20) -0.30 0.25 0.22 (0.20, 0.24) -0.13 0.25 0.21 (0.19, 0.23) -0.15
IR 0.50 0.49 (0.47, 0.51) -0.02 0.50 0.46 (0.42, 0.48) -0.08 0.50 0.47 (0.45, 0.49) -0.06
σ 10.00 9.47 (9.23, 10.01) -0.04 15.00 14.85 (14.79, 14.9) -0.01 20.00 20.26 (19.98, 20.34) 0.01
Scenario I3A Scenario I3B Scenario I3C
Variable θ  (95% CI)𝛉 RB θ  (95% CI)𝛉 RB θ  (95% CI)𝛉 RB
Intercept 2.90 2.94 (2.89, 2.99) 0.01 2.90 2.94 (2.88, 2.98) 0.01 2.90 2.92 (2.87, 2.97) 0.01
HUM 0.20 0.2 (0.18, 0.22) -0.01 0.20 0.19 (0.18, 0.21) -0.03 0.20 0.20 (0.18, 0.21) -0.02
NDVI 0.30 0.3 (0.28, 0.31) 0.00 0.30 0.30 (0.28, 0.31) -0.01 0.30 0.30 (0.28, 0.31) -0.01
RAIN 0.20 0.18 (0.16, 0.20) -0.10 0.20 0.18 (0.16, 0.20) -0.12 0.20 0.17 (0.15, 0.19) -0.15
TEMP 0.25 0.20 (0.18, 0.22) -0.18 0.25 0.23 (0.21, 0.24) -0.09 0.25 0.23 (0.21, 0.25) -0.10
IR 0.50 0.46 (0.43, 0.48) -0.08 0.50 0.48 (0.45, 0.49) -0.05 0.50 0.48 (0.46, 0.50) -0.03
σ 10.00 9.76 (9.72, 10.81) -0.02 15.00 14.48 (14.42, 15.00) -0.03 20.00 19.55 (19.27, 20.03) -0.02
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Supplementary material S3
Nelli L., Ferguson H.M., Matthiopoulos J.
Achieving depth and breadth in spatial models of vector-borne diseases: an integrated framework 
for active survey and passive surveillance data.
S3.1 – Plots as showing the relationship between the simulated and reconstructed malaria incidence 
by model 2.
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S3.2 – Plots as showing the relationship between the simulated and reconstructed malaria incidence 
by model 3.
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S3.3 – Plots as showing the relationship between the simulated and reconstructed insecticide 
resistance by model 3.
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